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INTRODUCTION
Viscum album L.	 (Santalaceae)	 (VA),	
commonly	 known	 as	 European	 Mistletoe,	 is	
a	 hemi-parasitic	 plant	 that	 grows	 on	 various	
trees.	VA	has	a	 long	 tradition	as	medicinal	plant,	
being	 used	 in	 traditional	 medicine	 as	 a	 popular	
remedy	 for	 hypertension,	 vascular	 disease,	
epilepsy,	 arthritis	 and	 rheumatism	 for	 centuries.	
Nowadays,	 mistletoe	 extracts	 are	 widely	 used	
as	 complementary	 therapy	 for	 cancer	 patients	
(Ostermann et al.,	2009).	
Viscum album preparations	 are	 used	 as	 a	
complementary	 medicine	 in	 cancer	 therapy.	
Although	 the	 beneficial	 properties	 of	 European	
mistletoe	 have	 been	 documented	 throughout	
history,	 its	 therapeutic	 application	 has	 been	
changing	with	the	development	of	science.
Recently,	 many	 in vitro	 and	 in vivo 




increase	 the	 survival	 time	 in	 different	 types	 of	
cancer	(Ostermann et al.,	2009). 
The	mistletoe’s	 antitumor	 effect	 is	 based	 on	
two	 distinct	 bioactivities:	 direct	 cytotoxic	 effect	
and	 the	 increase	 of	 the	 cell	 mediated	 immunity.	
The	 lectins	 are	 responsible	 for	 direct	 toxicity	
against	 tumor	 cells	 (Khil	 et al.,	 2007),	 while	
the	 oligosaccharides	 enhance	 the	 natural	 killer	
cells	 efficiency	 (Lee	 et al.,	 2009).	 In	 addition,	
mistletoe	 compounds	 (Tabiasco	 et al.,	 2002)	
selectively	activate	the	antitumor	human	cytotoxic	
T	 lymphocytes,	 while	 other	 VA	 compounds	
like	 triterpenes	 have	 also	 apoptotic	 properties	
(Nazaruk	 and	 Orlikowski,	 2015).	 	 However,	
VA	 is	 rarely	 used	 as	 the	 only	 systemic	 therapy;	
experimental	 and	 clinical	 studies	 showed	 that	
the	best	results	are	provided	by	association	with	
classic	 chemotherapy	 (Ostermann et al.,	 2009;	
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the	 selective	 cytotoxicity	 in vitro	 of	 a	 hydro-
alcoholic	VA	extract.	
MATERIALS AND METHODS   
Plant material.	 The	 VA	 (plant	 raised	 from	
the	apple	tree	–	Malus	communis)	was	harvested	
from	 Cluj	 area,	 in	 November	 –	 December	 2009.	
The	 vegetal	 products	 were	 dried	 and	 grounded	
to	a	fine	powder.	The	vegetal	products	were	used	
to	prepare	a	plant	ethanol	macerate,	according	to	




effect	 was	 performed	 both	 on	 normal	 human	
fibroblasts	 (Hfl)	 and	 on	 a	 tumor	 cell	 line	 (Hela).	
Fibroblasts	were	cultivated	in	DMEM/F12	(Sigma)	
suplimented	 with	 10%	 fetal	 calf	 serum	 (FCS,	
Hyclone),	1%	NEEA	(Non-Essential	Amino	Acids)	+	
1	50	µg/ml	gentamicin	and	5	ng/ml	amphotericin	
(Biochrom	 Ag,	 Berlin,	 Germany).	 Hela	 cells	
(obtained	 from	 M.	 Herlyn,	 the	 Wistar	 Institute,	








Cell toxicity assay.	 The	 cell	 cytotoxicity	
assay	 was	 performed	 using	 the	 MTT	 test,	
as	 specified	 by	 the	 manufacturer.	 The	 MTT	
assay	 involves	 the	 conversion	 of	 the	 water	
soluble	 MTT	 (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium	 bromide)	 to	 an	 insoluble	
formazan.	 The	 formazan	 is	 then	 solubilized,	 and	




and	 allowed	 to	 accommodate	 for	 24h	 in	 normal	
growth	conditions.	The	cultures	were	then	exposed	
to	 VA	 extract	 (prepared	 as	 described	 above)	 in	





control	 counterpart	 were	 incubated	 for	 2	 hours	
with	200	µl	of	MTT	.	The	formazan	was	solubilized	
with	 200	 µl	 DMSO	 (Dimethyl	 sulfoxide)	 and	 the	
absorbance	 of	 each	 sample	was	 read	 at	 490	 nm	
using	an	ELISA	microplate	reader.	
The	 IC50	 values	 representing	 the	 extract	




SEM.	 The	 Gaussian	 distribution	 was	 checked	 by	
the	Shapiro-Wilk	normality	test.	One-way	ANOVA	
followed	 by	 the	 Dunns	 post-test	 was	 the	 choice	
for	cell	viability	test.	Statistical	values	and	figures	
were	 obtained	 using	 GraphPad	 Prism	 version	
5.0	 for	Windows,	 GraphPad	 Software,	 San	 Diego	
California	USA.
RESULTS AND DISCUSSION   
Cell	 viability	 is	 gradually	 reduced	 in	 HeLa	
tumor	cell	line	from	44.58%	at	5	µg/ml	VA	extract,	
to	9.35%	at	the	dose	of	50	μg	/	ml.	HFL	cells	are	
not	 affected	 in	 the	 same	manner	 by	 the	 extract,	
63.65%		of	these	cells	are	viable	at	50μg	/	ml,	the	
highest	dose	tested	(Fig.	1).	 In	the	case	of	 tumor	
cells	 line	 significant	 differences	 were	 registred	
from	5	μg	/	ml	doses	up	 to	50μg	/	ml	 (p	<0.05)	
compared	 to	 control.	 The	 difference	 was	 visible	




Weissenstein	 et al. (2014)	 explored	 the	
antiproliferative	 effect	 of	 VA	 extracts,	 on	 several	
tumor	lines	in	higher	doses.	In	the	present	study,	
we	 obtained	 the	 inhibition	 at	 a	 much	 lower	
concentrations,	50μg	/	ml	as	compared	to	100	mg	
/	 ml.	 These	 differences	 may	 be	 due	 to	 different	
methods	 of	 obtaining	 the	 extracts	 or	 to	 the	
different	sensibility	of	the	tumor	cell	lines	used.
Previous	 in vivo	 and	 in vitro	 studies	 proved	
that	 mistletoe	 extracts	 had	 certain	 antitumor	
effects	 (Cebovic	 et al.,	 2008,	 Khil	 et al.,	 2007;	
Sevastre	et al.,	2010,	Sárpataki	et al.,	2011,	2014).	
Antitumor	 mechanism	 is	 still	 to	 be	 established,	
but	 there	 are	 two	 distinct	 hypotheses	 accepted,	












of	 initiating	apoptosis	 (Janssen	et al.,	1993).	The	
content	 of	 active	 compounds	 (especially	 lectins)	
of	extract	varies	greatly	depending	on	the	time	of	
harvesting	 the	 plant	 and	 its	 origin.	 According	 to	
Kovacs	(2010)	an	aqueous	unfermented	extract	of	
mistletoe	plants	seems	to	inhibit	the	proliferation	
of	 the	 cells	 (cytostatic	 effect),	 arrests	 cell	 cycle	




CONCLUSION   
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Fig.3.	Hfl	cells.	A	Control	B	50μg	/	ml,	cells	had	a	lower	density,	but	no	obvious	toxicity	signs	were	seen.	(x400).	
